EGFR-mutation-positive non-small-cell lung cancer (3rd-gen TKI).
Osimertinib
Brand reference: Tagrisso (AstraZeneca, India)
View medicine detailsGenuine, licensed cancer medicines
Search by medicine name, active ingredient or brand reference. Every enquiry is checked against a current prescription before anything proceeds.
Medrack helps patients and caregivers prepare a prescription-led referral enquiry.
Featured medicines
Explore featured medicines
Browse a selection of commonly searched medicines, with active ingredients and brand references to help you find the relevant listing. Featured listings are informational and do not indicate availability or suitability for a specific patient.
Advanced prostate cancer (androgen-receptor inhibitor).
Enzalutamide
Brand reference: Bdenza
View medicine detailsStrength40 mg
Hormone-sensitive breast cancer.
Letrozole
Brand reference: Letrozole
View medicine detailsStrength2.5 mg
Hormone-sensitive breast cancer.
Anastrozole
Brand reference: Anazol
View medicine detailsStrength1 mg
Renal cell, liver and thyroid cancers.
Sorafenib tosylate
Brand reference: Sorafenib
View medicine detailsStrength200 mg
One consolidated enquiry
Review enquiry listAdd every prescribed medicine, then send the details together.
Record the strength and quantity shown on the prescription. When the list is ready, provide the patient details and current prescription through the secure form.
What happens next
Submit the prescription for a case-specific assessment.
Medrack reviews the medicine, destination and documents before explaining whether there may be an appropriate next step. Your treating oncology team remains responsible for clinical decisions.